The Safety and Tolerability of Secretrol in Patients With Barrett's Esophagus
Clinical trial NCT01905202 · UNKNOWN
Trial details
- NCT number
- NCT01905202
- Sponsor
- Effexus Pharmaceutical
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-04-01
- Primary completion
- 2015-04-01
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.